Biotech · Private company · Evanston, IL, US
Angiotensin Therapeutics, Inc.
Track this companyFree. Adds Angiotensin Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- AGT001 for Delayed Graft Function in Kidney TransplantationFiscal year 2025 · $314.4KNIH RePORTER 1R41DK142544-01A1 · fetched Nov 12, 2026
- AGT001 for Scleroderma KidneyFiscal year 2025 · $295.7KNIH RePORTER 1R43DK143839-01A1 · fetched Nov 12, 2026